Atlas Trials

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Clinical trial NCT04639375 · UNKNOWN

Trial details

NCT number
NCT04639375
Sponsor
E-MO Biology Inc
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2020-11-15
Primary completion
2021-06-12
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.